Fiche centre
Wasatch Clinical Research, LLC
Salt Lake City — United States
Essais liés4clinical trials
VilleSalt Lake Citylocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06995729
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Zavegepant | Migraine | Phase 1 | NCT06995729 | A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine | RECRUITING |
| Elismetrep | Migraine | Phase 3 | NCT07816367 | A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | RECRUITING |
| Rimegepant | Migraine | Phase 3 | NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | ACTIVE_NOT_RECRUITING |
| Xanomeline/Trospium Chloride Capsule | Alzheimer | Phase 3 | NCT07011732 | A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) | RECRUITING |